Assessing the benefits of ICD implantation in patients with coronary artery disease after cardiac arrest
Official title: A Danish Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients with Coronary Artery Disease Resuscitated from Ventricular Fibrillation Who Receive Complete Revascularization
Run by Copenhagen University Hospital, Rigshospitalet · NCT04576130 · Data updated 2026-11-12
This study is testing if getting an implantable defibrillator helps people with coronary artery disease who have survived a cardiac arrest feel better and live longer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 1 site (Copenhagen) |
| Status | Recruiting |
| Started | October 12, 2020 |
| Main results expected | October 2032 |
| Study ends | October 2032 |
| Registry record updated | January 27, 2025 |
| Trial ID | NCT04576130 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with coronary artery disease who have survived cardiac arrest due to ventricular fibrillation or sustained ventricular tachycardia and have undergone complete revascularization.
✕Probably not a fit
Patients with non-ischemic causes of cardiac arrest or those with a life expectancy of less than one year may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates whether implantable cardioverter defibrillator (ICD) implantation provides benefits to patients with coronary artery disease who have survived cardiac arrest due to ventricular fibrillation or sustained ventricular tachycardia. Participants will undergo complete revascularization before receiving the ICD, and the study will focus on those with a left ventricular ejection fraction (LVEF) above 35%. The aim is to determine the effectiveness of ICDs in improving outcomes for these patients.
Why it matters
Potential benefit: If successful, this study could significantly improve survival rates and quality of life for patients with coronary artery disease who experience cardiac arrest.
How similar studies have gone: Previous studies have shown promising results with ICD implantation in similar patient populations, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with CAD and cardiac arrest due to VF/VT, where angiogram is performed with complete revascularization (PCI, CABG or hybrid coronary revascularization) before ICD implantation. Unfavorable artery for PCI (i.e., excessive vessel tortuosity or chronic total occlusion) or high-risk invasive treatment is not mandatory in order to achive complete revascularization. * Age ≥18 years * LVEF \>35% at the time of discharge. The most recent LVEF assessment on which the current medical treatment will be based at the time of entry into the study will be used as baseline LVEF. Exclusion Criteria: * Non-ischemic cause of cardiac arrest (i.e. ion channel diseases, non-ischemic cardiomyopathy) * Previous CABG within the last 3 months before index hospitalization * Life expectancy less than 1 year or severe neurologic outcome * Unable or unwilling to give informed consent * Pregnancy
Where it's running
-
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark Recruiting
Study contacts
- Principal investigator: Reza Jabbari, MD, PhD — Copenhagen University Hospital, Rigshospitalet
- Study coordinator: Reza Jabbari, MD, PhD
- Email: reza.jabbari.02@regionh.dk
- Phone: +4535455380
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early double sequential defibrillation for cardiac arrest outside the hospital
We test whether using two defibrillators in quick succession after the first failed shock helps adults with out‑of‑hospital cardiac arrest and a shockable rhythm survive more often than continuing standard single shocks.
-
Initial double sequential defibrillation for out-of-hospital ventricular fibrillation
This trial will test whether using two defibrillators to give double sequential shocks first improves survival for adults with out-of-hospital cardiac arrest and a shockable rhythm.
-
Long-term follow-up of patients with acute myocardial infarction
This study is trying to see how patients who have had a heart attack can be better monitored over time using new technology to improve their health and prevent future heart problems.
-
Effect of early nasal cooling on survival after cardiac arrest
This study is testing if cooling patients right after a cardiac arrest can help them survive better and recover their brain function compared to standard care.
-
Using advanced cardiac imaging to improve treatment for patients with chest pain
This study is testing if using advanced heart imaging techniques can help people with chest pain get better treatment and feel healthier compared to standard care.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.